Pieris Pharmaceuticals, Inc. (PIRS) Stock Analysis
DELISTED 2024
What happened to Pieris Pharmaceuticals, Inc. (PIRS) stock?
Pieris Pharmaceuticals, Inc. (PIRS) no longer trades on public markets. It was delisted in December 2024. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- December 2024
- Last recorded price (historical):
- $13.60 (last quote on record before the December 2024 delisting; historical, not a current quote)
Market cap $18.0M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Pieris Pharmaceuticals, Inc. (PIRS). Pieris Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing Anticalin-based drugs. Their pipeline targets respiratory diseases and immuno-oncology, with several candidates in clinical trials and collaborations with major pharmaceutical companies.
Last analyzed: May 9, 2026Pieris Pharmaceuticals, Inc. (PIRS) Healthcare & Pipeline Overview
More about this archive record
Can I still buy PIRS shares?
No. PIRS stopped trading on public markets in December 2024, so the shares are not available through a broker. Anything you see quoted for PIRS elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before PIRS stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Pieris Pharmaceuticals, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.